Ray Lameng Lei

Title: Ray Lameng Lei: Innovator in Pharmaceutical Aerosol Formulations

Introduction

Ray Lameng Lei is a notable inventor based in Rancho Cucamonga, California. He has made significant contributions to the field of pharmaceutical aerosol formulations, particularly in the development of environmentally friendly inhalation therapies. His innovative work focuses on improving the efficacy and safety of medication delivery systems.

Latest Patents

Ray Lameng Lei holds a patent for an "Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent." This formulation utilizes pre-micronized albuterol sulfate combined with a high amount of the green propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze(E)). The unique aspect of this formulation is that it is co-solvent-free, meaning it does not contain any co-solvents such as ethanol, glycerol, or propylene glycol. This innovation allows for highly efficient delivery of albuterol particles through a metered dose inhaler (MDI), ensuring improved safety and a lower global warming potential.

Career Highlights

Ray Lameng Lei is currently associated with Amphastar Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical formulations. His work has been pivotal in enhancing the delivery mechanisms of respiratory medications, contributing to better patient outcomes.

Collaborations

Throughout his career, Ray has collaborated with esteemed colleagues such as Jack Yongfeng Zhang and Ying Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Ray Lameng Lei's contributions to pharmaceutical aerosol formulations exemplify the intersection of innovation and environmental responsibility. His work not only enhances medication delivery but also prioritizes safety and sustainability.